Navigation Links
SemBioSys announces 2007 third quarter results
Date:11/1/2007

123,039 and $390,570 for the corresponding periods in 2006. The difference in revenue relates primarily to the recognition of an upfront license fee payment received from Martek in the first quarter of 2007 as well as contract research revenue recognized in the first half of 2007 and three-month and nine-month periods ended September 30, 2006.

Total expenditures for the three-month and nine-month periods ended September 30, 2007 were $4,022,642 and $12,017,416 respectively, compared with $2,949,791 and $10,706,226 for the corresponding periods last year.

Research and development expenses for the three-month and nine-month periods ended September 30, 2007 were $1,892,224 and $5,560,941 respectively, compared with $1,360,045 and $3,843,207 for the corresponding periods last year. The difference is primarily from increased personnel and outsourcing related to preclinical costs and the related support costs in all areas of research and development with an expanded focus on insulin and Apo AI. As SemBioSys prepares to enter clinical trials, all lab related activities continue to substantially increase resulting in a higher overall cost. The Company has also expanded the plant growth team and infrastructure both indoors and in the field as its programs further progress.

General and administrative expenses for the three-month and nine-month periods ended September 30, 2007 were $1,041,949 and $3,152,426 respectively, compared with $903,753 and $2,695,669 for the corresponding periods last year. The difference is mainly due to newly added staff to support expanded operations and increased investor relations activities as the Company broadens its exposure to U.S. and European markets.

Intellectual property costs for the three-month and nine-month periods ended September 30, 2007 were $237,430 and $1,073,093 respectively, compared with $217,269 and $2,561,564 for the corresponding periods last year. This difference in the nine-month period is primarily
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... LAKES, N.J. , July 22, 2014 The ... BDX ) has declared a quarterly dividend of ... to holders of record on September 9, 2014. The indicated ... About BD BD is a leading medical technology ... of the world,s most pressing and evolving health needs. Our ...
(Date:7/22/2014)... Terry Baughn, a senior lecturer in mechanical engineering at ... Engineer of the Year by the North Texas section ... ASME has more than 130,000 members in 158 countries ... technology to assist the engineering community, benefiting the world. ... Texas Society of Professional Engineers honors banquet. Baughn retired ...
(Date:7/22/2014)... 22, 2014 Automated cell culture systems ... of cell culture. They allow production of optimum cells ... researchers in drug discovery and industries and biopharmaceutical companies. ... production, iPSC research, cryobanking, cell-based assays, and cellular expression ... , Analysts forecast the Global Cell Culture market ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 OHAUS ... portable, and mechanical balances and scales, proudly announces ... has won Laboratory Equipment magazine’s 2014 “Readers' Choice” ... second consecutive year the Explorer was voted the ... annual Readers’ Choice Awards celebrates “excellence in product ...
Breaking Biology Technology:UT Dallas professor receives Engineer of the Year award 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2
... Verenium,Corporation (Nasdaq: VRNM ), a leading developer ... development of high-performance specialty,enzymes, announced today that John ... Financial Officer, will present at the upcoming,Piper Jaffray ... to begin at 10:00 a.m. ET on Wednesday, ...
... and Reduce the ... Conn., Feb. 13 VION,PHARMACEUTICALS, INC. (Nasdaq: VION ) ... Omni Hotel in New Haven, Connecticut today at,10:00 Eastern Time., ... the,Company,s Restated Certificate of Incorporation to:, -- effect ...
... Company Posts Fourth Quarter EPS of $0.37, Up 16% -, - For ... Up 41%; Total Revenues and Product ... Income Growth in Four Years, ... $1.72 -, SAN DIEGO, Feb. 13 Gen-Probe Incorporated,(Nasdaq: GPRO ...
Cached Biology Technology:Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference 2Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference 3Vion Pharmaceuticals Holds Special Meeting of Stockholders 2Vion Pharmaceuticals Holds Special Meeting of Stockholders 3Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 2Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 3Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 4Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 5Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 6Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 7Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 8Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 9Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 10Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 11Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 12Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 13Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 14Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 15Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007 16
(Date:7/22/2014)... published research in the Journal of ... dopamine signaling and dopamine transporter function are ... early-onset Parkinsonism and attention deficit hyperactivity disorder ... a critical basis for further exploration of ... function contribute to brain disorders" said Michelle ...
(Date:7/22/2014)... 14, 2014, by lightning from a weather system that moved ... fires: Stokes Fire, Gold Hikes Fire, French Creek Fire and ... now one larger fire. The fires are burning in timber ... acres in size. The present fire situation continues to ... firefighter safety is the priority on the Carlton Complex fires. ...
(Date:7/22/2014)... new study that examined the survival rates of ... in commercial longline fishing operations found large differences ... thresher, dusky, and scalloped hammerhead being the most,vulnerable. ... of Miami (UM) Rosenstiel School of,Marine and Atmospheric ... and Policy, provides,new information to consider for future ...
Breaking Biology News(10 mins):The dopamine transporter 2The dopamine transporter 3New study reveals vulnerability of sharks as collateral damage in commercial fishing 2
... with high levels of the virus associated with cervical ... 27 times, according to a study published in the ... , Anthony Gunnell, a medical biostatistician and epidemiologist ... the medical exams of women with non-invasive cervical cancer ...
... parasite on earth: It infects hundreds of species of ... ability to overcome the numerous challenges of infecting and ... long intrigued scientists, and now researchers at the Stanford ... proteins critical to its ability to thrive. , The findings ...
... of heme oxygenase-1 (HO-1), an antioxidant that protects against ... tissue injury), become elevated in the lungs of chronic ... for the disease. , These results appear in the ... of Respiratory and Critical Care Medicine, published by the ...
Cached Biology News:High HPV concentrations combined with smoking significantly raise risks of cervical cancer 2High HPV concentrations combined with smoking significantly raise risks of cervical cancer 3Stanford discovery may help predict when toxoplasma can be deadly 2Stanford discovery may help predict when toxoplasma can be deadly 3Antioxidant protects against lung damage in silicosis 2
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
IHC detection kit for PCNA in cells and tissues...
... HandyStep electronic from BRAND adds ergonomics ... is the only electronic, motor-driven repeating ... tips, including BRAND PD-Tip syringe tips, ... Dispenser Tips,and VWRbrand Combi-Syringes. Select virtually ...
Biology Products: